Daily TIP

NJ Gubernatorial Candidate Distances Himself from Boycott-Supporting Running Mate

Posted by Tip Staff - October 09, 2017

NJ Gubernatorial Candidate Distances Himself from Boycott-Supporting Running Mate
Iranian General: Law Designating Revolutionary Guards as Terror Group Violates Nuke Deal
Senate Unanimously Passes Bipartisan Bill Targeting Hezbollah Financing
Israeli Company Develops Revolutionary Artificial Cornea Implant


NJ Gubernatorial Candidate Distances Himself from Boycott-Supporting Running Mate

New Jersey’s Democratic candidate for governor, Phil Murphy, said on Friday that he disagrees with his running mate, Sheila Oliver, over her support for the boycotts campaign against Israel, an fringe movement that calls for the elimination of the Jewish state.

The Associated Press reported that, at an unrelated event in Lawrenceville last week, Murphy said that he would have supported the legislation that incumbent Republican Gov. Christ Christie signed into law last year.In June 2016, Sheila Oliver was one of just three legislators to vote against the bipartisan landmark anti-BDS law which prohibits the state’s public worker pension fund from investing in companies that engage in the boycott of Israel.

“It is important to the economic well-being of New Jersey that persons or entities conducting commercial trade and doing business in the State do not engage in boycotts of a legitimate and viable partner with whom New Jersey can enjoy open trade contracting,” the legislation reads.

In September of this year, State Senator, Daniel Biss, announced that he had dropped his running mate, Alderman Carlos Ramirez-Rosa, in his bid for the Democratic nomination for Illinois governor, over Ramirez-Rosa’s support for the boycotts campaign against Israel.

The Israel Project’s CEO, Joshua Block, hailed Biss’ decision as “an important victory against hatred and intolerance.” Block added that the move sets “a standard for the rest of the country that, when you need to move left to win a primary, there is a red line on Israel that makes supporting BDS — on its own — disqualifying for candidates for state-wide office.”



Iranian General: Law Designating Revolutionary Guards as Terror Group Violates Nuke Deal

Implementing a law that designate Iran's powerful Islamic Revolutionary Guard Corps (IRGC) as a terrorist group would violate the 2015 nuclear deal with Iran, an IRGC general said Sunday.

Major General Mohammad Ali Jafari, the top commander of the IRGC also issued a veiled threat saying that enforcing the law that passed both houses of the United States legislature with overwhelming bipartisan majorities would prompt Iran to "consider the American military all over the world, especially the Middle East, as equal to Daesh," referring to ISIS, the semi-official Iranian news agency, PressTV reported.

"As we have announced in the past, if America's new law for sanctions is enforced, this country will have to move its regional bases outside the 2,000 km radius of the Iranian missiles' range," Jafari added.

Iran, according to Jafari, considers implementation of Countering America’s Adversaries Through Sanctions Act, “equal to America’s unilateral withdrawal from the JCPOA,”as the nuclear deal is known. This would prompt Iran to greatly improve the capability of its missiles. United Nations Security Council resolution 2231, which implements the nuclear deal, calls on Iran not to develop ballistic missiles..

Jafari's claim that targeting the IRGC would violate the nuclear deal contradicts a common claim made by supporters of the nuclear deal as well as Iran that the deal was meant only to address Iran's nuclear program. For example, Gholamali Khoshroo, Iran’s ambassador to the UN wrote in an op-ed published Sunday in The New York Times, “It was always clear that the path to reaching a nuclear deal meant setting aside other geopolitical concerns.”



Senate Unanimously Passes Bipartisan Bill Targeting Hezbollah Financing

On Thursday, the United States Senate passed the Hizballah International Financing Prevention Amendments Act of 2017 (S. 1595), which seeks to cut off the flow of resources to the Lebanese-based terrorist organization. The bipartisan legislation was introduced by Sens. Marco Rubio (R-Fla.) and Jeanne Shaheen (D-N.H.).

“Iranian-backed Hizballah terrorists are responsible for the deaths of hundreds of Americans, and continue to pose grave threats to the United States and our allies, including the democratic state of Israel,” Rubio said in a statement. “Congress should exercise every tool at its disposal to confront Iran’s destabilizing activity in the region…particularly in Lebanon, where Hizballah continues to stockpile rockets and other weapons that directly threaten our ally Israel and provide military support to the murderous Syrian dictator Bashar al-Assad,” Shaheen added.

The new legislation strengthens and expands the scope of economic and financial sanctions imposed on the terrorist group by previous legislation, the Hizballah International Financing Prevention Act of 2015.

It is a significant development in light of Hezbollah’s destabilizing regional activities and the group’s global reach to areas in the Western Hemisphere, where Hezbollah is involved in organized crime. The organization has been linked to drug trade, trafficking of exotic animals, and black-market sales of precious metals to finance its terror activities and its fighting in support of the Assad regime in Syria. An estimated 20 to 30 percent---or between $200 and $300 million per year---of Hezbollah’s $1 billion annual budget comes from sources other than the Iranian regime.



Israeli Company Develops Revolutionary Artificial Cornea Implant

An early-stage Israeli ophthalmic medical devices startup has developed a revolutionary artificial cornea implant that holds out hope to millions of blind and visually impaired people suffering from diseases of the cornea.

The nanotech-based solution by CorNeat Vision of Ra’anana is a synthetic cornea that uses advanced cell technology to integrate artificial optics within ocular tissue.

After successful initial tests on animals, the company plans to move to human implantations in Israel in the middle of next year, and also to begin a larger clinical trial of 20 to 60 patients in the United States.

According to the World Health Organization, diseases of the cornea are the second leading cause of blindness worldwide, second only to cataracts. As many as 30 million people are affected.

“Though [corneal diseases are] a profound cause of distress and disability, existing solutions such as corneal transplantation are carried out only about 200,000 times a year worldwide,” said 47-year-old CorNeat Vision CEO and VP R&D Almog Aley-Raz.

CorNeat KPro uses advanced cell technology to integrate artificial optics within resident ocular tissue. The implant is produced using nanoscale chemical engineering that stimulates cellular growth.

“Unlike previous devices, which attempt to integrate optics into the native cornea, CorNeat’s implant leverages a virtual space under the conjunctiva that is rich with fibroblast cells, heals quickly and provides robust long-term integration,” said Aley-Raz.

The surgical procedure takes just 30 minutes, and the company believes it can provide an efficient and scalable remedy for millions.

(via Israel21c)


Be the first to comment

Please check your e-mail for a link to activate your account.